ArticleCureus2026
Primary Epithelioid Angiosarcoma of the Right Atrium Presenting With Symptomatic Bradycardia: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cardiac angiosarcoma is a rare and aggressive malignancy that mainly affects the right atrium of the heart. In this report, we present a rare variant known as cardiac epithelioid angiosarcoma. Due to its rarity, the epidemiology and pathogenesis of this disease are not well understood. We present the case of a 44-year-old woman who presented with palpitations, chest pain, and symptomatic bradycardia. Multimodal imaging identified a large, sessile right atrial mass. The location of the mass near the sinoatrial node region likely contributed to the patient's bradycardia. The patient underwent surgical resection with bovine pericardial patch reconstruction. Histopathology favored epithelioid angiosarcoma, and the margins were unclear due to specimen fragmentation. The postoperative course was complicated by junctional rhythm bradyarrhythmia requiring pacing. Comprehensive staging, including brain MRI and CT of the chest, abdomen, and pelvis, ruled out distant metastasis. The patient was deemed not to be a candidate for radiation therapy due to the tumor's location in the heart. Although adjuvant AIM chemotherapy (doxorubicin, ifosfamide, mesna) was recommended by oncology, the patient opted for observation, given the limited expected benefit of chemotherapy. This case highlights the complexity of managing primary cardiac angiosarcoma, particularly when standard therapeutic options are limited, and underscores the need for individualized, multidisciplinary care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.